CRM Research Update — September 22, 2026
Updated Thesis
Salesforce is the leading enterprise customer relationship management platform, spanning Sales, Service, Platform, Marketing, Commerce, Tableau, MuleSoft, and Slack under the Customer 360 umbrella, with 83,334 employees and a business that converts $53.65 of revenue per share into $18.48 of free cash flow per share. Business quality is high: TTM gross margin of 77.3%, TTM operating margin of 21.4%, TTM net margin of 22.0%, and ROE of 20.2% reflect a scaled, high-retention software model, while revenue growth of 10.8% and earnings growth of 86.9% in the most recent quarter show a company that has shifted decisively from growth-at-all-costs to margin and cash generation. The stock trades at $236.42 against a blended fair value estimate of $263.88, implying 11.6% upside, with a P/S of 4.41, trailing P/E of 20.06, P/FCF of 12.79, and EV/EBITDA of 14.37 — multiples that sit in a cheap regime relative to the company's own five-year history.
The investment grade as of this refresh is B — solid business quality. A-tier business, B-tier valuation with 11.6% upside to $263.88 fair value.
Key Metrics at a Glance
- Revenue growth: +10.8% year over year
- Net margin: 22.0%
- Fair value upside: +11.6% to our estimate of $264
Current price: $236.42
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Salesforce, Inc. remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CRM research →](/stocks/CRM)